Blog
The Launch Lens: Trends in Payer Management Across Archetypes for New...
5 Minute Read
The pharmaceutical market continues to introduce an array of new therapies across archetypes including many potentially transformative entrants across specialty, rare disease, and precision medicine. An analysis of commercial...
Market Access Advisory I Regulatory & Legislative Intelligence
6 Minute Read
Myth vs. Reality: What Biopharmaceutical Manufacturers Must Understand About the New Regulatory Landscape.
The Evolving Role of Trade and Channel Data in Net Revenue...
3 Minute Read
Trade and channel operations have traditionally been viewed as operational functions focused on execution and reconciliation. However, that perception is shifting as manufacturers face increasing pricing pressure, regulatory scrutiny,...
Technical Evolution of Net Revenue Management: Precision Data Architecture, Validation Logic,...
4 Minute Read
Pharmaceutical net revenue management has entered a phase where structural complexity, data volume, and regulatory pressure now exceed the functional limits of traditional net revenue management systems.
CY 2026 Medicare Final Rules: Your Pharma Compliance Checklist for PFS,...
5 Minute Read
Our latest blog offers a detailed breakdown of the new manufacturer discount program invoices and assesses the implications of adding Part B drugs to the IPAY 2028 and MFP.
Pharma/Biotech CFO Industry Insights on Net Revenue Optimization
6 Minute Read
Why CFOs are shifting from Reactive Net Revenue Management to Proactive Net Revenue Optimization? By Jen Sharpe, VP, Advisory Services at IntegriChain.
Unpacking IPAY 2028: Part B Drugs, New Invoices, and the MFP
6 Minute Read
Our latest blog offers a detailed breakdown of the new manufacturer discount program invoices and assesses the implications of adding Part B drugs to the IPAY 2028 and MFP.
Unifying Data for Commercialization of Pharmaceutical Products in the New Era
3 Minute Read
The pharmaceutical industry stands at a pivotal juncture, navigating a complex landscape marked by evolving drug archetypes, escalating costs, and stringent regulations. In this dynamic environment, the ability to...
Taming Launch Data Chaos: Why Your Bespoke Pharma CDW Can’t Keep...
2 Minute Read
The pharmaceutical landscape, particularly during launch, is drowning in data. Specialty Pharmacy (SP) and Specialty Distributor (SD) data streams are critical lifelines, offering insights into prescribing behavior, patient access,...